Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Grace Therapeutics, Inc GRCE

Healthcare
Grace Therapeutics, Inc., formerly Acasti Pharma Inc., is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of over 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is a clinical-stage, novel... see more

Bullboard (NDAQ:GRCE)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Comment by Francine01on Aug 10, 2020 9:10am

RE:RE:T2 Data Release

T2 topline release won't be before August 26th for the simple reason that shareholders vote for board directors and stock options plan is closing August 26th.  Management doesn't want ...more  
177
Discussion
Comment by Danny1082Manon Aug 09, 2020 10:26pm

RE:RE:T2 Data Release

Their requirement to release pertinent info runs longer than 10 days. So my comments stand
119
Discussion
Comment by EternalPonzion Aug 09, 2020 8:56pm

RE:T2 Data Release

Once in hand they are compelled to release the results, good or bad, within a reasonable time. Those are the rules.
120
Discussion
Post by Danny1082Manon Aug 09, 2020 8:05pm

T2 Data Release

Though the PR said expect T2 topline data "on or before Aug 31st", which is a Monday, we know they will have in hand well before that. If it meets it's primary endpoint I would expect ...more  
285
Discussion
Post by Rosmorducon Aug 04, 2020 1:31pm

Question to ask yourself if you want to sell a stock:

Would you buy more here? If yes, then you don't sell the stock. This strategy works wonders. 
197
Comment by willyk3on Aug 03, 2020 4:48pm

RE:RE:Nice to see the pop

Ive told that story before...regrettably..  Note also the huge volume on some of these up days
140
Discussion
Comment by Rosmorducon Aug 03, 2020 9:18am

RE:Nice to see the pop

If you play it that way, you might suddenly miss the huge upside and then kick yourself for swinging pennies but missing the dollars.  Remember that a stock goes up for one reason only: demand ...more  
206
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities